Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

4(80.0%)

Phase 2

1(20.0%)

5Total

N/A(4)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT03855449Not ApplicableCompleted

A Task Analysis Study of DECIDE For African American Patients With Type 2 Diabetes

Role: collaborator

NCT07036354Not ApplicableActive Not Recruiting

Evaluation of the Effects of Human-Animal Interaction on Anxiety in Graduate Students

Role: lead

NCT06442306Not ApplicableCompleted

Evaluation of Pain Neuroscience Education for Patients Who Experience Chronic Pain With Concurrent Opioid Dependence

Role: lead

NCT02648165Not ApplicableCompleted

Secondary Prevention of Depression Through Group-based ACT-Therapy Preceded by an Experimental ABM-Procedure

Role: collaborator

NCT05709704Unknown

Comparison of Overall Function Between Postpartum Women With and Without Diastasis Rectus Abdominis

Role: collaborator

NCT03868202Phase 2Unknown

Follicle Stimulating Hormone (FSH) Glycosylation in Women: Effect of Estradiol

Role: collaborator

All 6 trials loaded